C0017428||Genomic
C1332838||targeted genes
C0238461||anaplastic thyroid cancer
C0007634||cell lines
C0238461||Anaplastic thyroid cancer
C0238461||Anaplastic thyroid cancer
C0442867||malignant disease
C0544886||somatic mutations
C0017428||genomic
C0238461||Anaplastic thyroid cancer
C0008625||aberrations
C0178648||gene fusions
C0752248||gene expression patterns
C0026882||mutations
C0007634||passage cells
C0238461||Anaplastic thyroid cancer
C0007634||cell lines
C3536614||single nucleotide polymorphism (SNP) array analysis
C0162327||RNA sequencing
C3640077||whole exome sequencing
C0238461||Anaplastic thyroid cancer
C0007634||cell line
C0017428||genomes
C0598312||replicative
C0243095||stress
C0919532||genomic instability
C0002938||aneuploidy
C2612372||centromeric regions
C0677504||fragile sites
C0524869||Loss of heterozygosity
C0450238||whole chromosomes
C1513916||no
C3828843||near-haploidisation events
C4277538||chromothripsis
C1533585||fusion genes
C0178648||in-frame fusions
C1880945||Global gene expression analysis
C0017337||genes
C0017262||expressed
C0238461||Anaplastic thyroid cancer
C0238463||papillary thyroid cancer
C0007634||cell lines
C0936012||pathway enrichment analyses
C0013081||downregulation
C0079419||TP53
C3537152||signalling
C0007578||cell adhesion molecules
C0238461||Anaplastic thyroid cancer
C0026882||mutations
C0812241||BRAF
C0809246||NRAS
C0079419||TP53
C1367342||TERT
C0086860||promoter
C1419114||PTPRD
C1424887||NEGR1
C1332838||target genes
C0238461||Anaplastic thyroid cancer
C0008628||deletions
C0007634||cell lines
C0017337||gene
C0544886||somatic mutation
C0007634||cell line
C0007621||tumourigenesis
C0238461||Anaplastic thyroid cancer